Press Releases DiaSorin S.p.A.

Equities

DIA

IT0003492391

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-04-29 EDT			After market 15:11:18
96.24 ^EUR	+1.41%		96.1	-0.15%

04-24	Citadel Advisors initiates short on STMicroelectronics.	AN
04-23	Reduced a short on DiaSorin, increased on STM.	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiaSorin S p A : submits LIAISON PLEX® Yeast Blood Culture Assay for the LIAISON PLEX® system to the U.S. FDA	03-13	PU
Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com	23-10-23	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2023	23-08-02	PU
DiaSorin S p A : Presentazione Risultati H1 2023	23-07-27	PU
DiaSorin S p A : launches the LIAISON® Legionella Urinary Ag assay in all countries accepting the CE Mark to improve diagnosis of legionnaires’ disease	23-07-17	PU
DiaSorin S p A : launches the LIAISON® B·R·A·H·M·S MR-proADM™ assay in all countries accepting the CE Mark	23-06-13	PU
DiaSorin S p A : CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM	23-05-25	PU
DiaSorin S p A : Presentazione Risultati Q1 2023	23-05-09	PU
DiaSorin S p A : Annual Financial Report at December 31, 2022	23-04-28	PU
DiaSorin S p A : Presentazione Risultati FY 2022	23-03-27	PU
DiaSorin S p A : Simplexa® cCMV Direct assay received U.S. FDA 510(K) clearance	22-11-09	PU
DiaSorin S p A : - 9M 2022 results presentation	22-10-27	PU
DiaSorin S p A : - Presentazione risultati primi 9 mesi 2022	22-10-27	PU
DiaSorin S p A : furthers its collaboration with BARDA for the LIAISON NES	22-10-05	PU
DiaSorin S p A : Roadshows Presentation -Settembre 2022	22-09-13	PU
DiaSorin S p A : Half-Year Financial Report at June 30, 2022	22-08-09	PU
DiaSorin S p A : Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards	22-08-03	PU
DiaSorin S p A : risultati H1 2022	22-08-03	PU
DiaSorin S p A : receives FDA 510(k) clearance for its LIAISON® MeMed BV® test	22-07-14	PU
DiaSorin S p A : Execution of the project for the redefinition of the corporate structure of DiaSorin	22-06-07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DIASORIN : Profitability guidance miss; dreams inching towards reality

March 18, 2024 at 05:24 am